{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo&page=87", "query": { "intervention": "Placebo", "page": 87 }, "page_size": 10 }, "pagination": { "page": 87, "page_size": 10, "total_count": 4245, "total_pages": 425, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo&page=88&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo&page=86&page_size=10" }, "source": "local", "last_synced_at": "2026-10-16T17:30:15.810Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT07527910", "title": "A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)" ], "interventions": [ { "name": "ALN-PNP", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Tirzepatide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Regeneron Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 204, "start_date": "2026-05-22", "completion_date": "2030-03-15", "has_results": false, "last_update_posted_date": "2026-09-29", "last_synced_at": "2026-10-16T15:35:03.243Z", "location_count": 9, "location_summary": "Tucson, Arizona • Coronado, California • Pasadena, California + 6 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Coronado", "state": "California" }, { "city": "Pasadena", "state": "California" }, { "city": "Jupiter", "state": "Florida" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07527910" }, { "nct_id": "NCT07288320", "title": "An Assessment of Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults With Bipolar I Disorder With Current Mania", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Bipolar I Disorder", "Mania" ], "interventions": [ { "name": "NBI-1117568", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Neurocrine Biosciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 150, "start_date": "2025-12-24", "completion_date": "2028-02", "has_results": false, "last_update_posted_date": "2026-09-29", "last_synced_at": "2026-10-14T18:39:15.650Z", "location_count": 11, "location_summary": "Little Rock, Arkansas • Cerritos, California • Garden Grove, California + 8 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Cerritos", "state": "California" }, { "city": "Garden Grove", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Hollywood", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07288320" }, { "nct_id": "NCT07282821", "title": "Bempedoic Acid Therapy for Polycystic Kidney Disease", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "ADPKD (Autosomal Dominant Polycystic Kidney Disease)" ], "interventions": [ { "name": "Bempedoic Acid 180 MG Oral Tablet", "type": "DRUG" }, { "name": "Placebo Capsule(s)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Kenneth Hallows", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 120, "start_date": "2026-09", "completion_date": "2030-03-31", "has_results": false, "last_update_posted_date": "2026-09-29", "last_synced_at": "2026-10-16T12:40:13.727Z", "location_count": 3, "location_summary": "Baltimore, Maryland • Boston, Massachusetts • Burlington, Vermont", "locations": [ { "city": "Baltimore", "state": "Maryland" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Burlington", "state": "Vermont" } ], "official_url": "https://clinicaltrials.gov/study/NCT07282821" }, { "nct_id": "NCT07280156", "title": "A Study to Investigate the Clinical Effect and the Safety of PRX-115 Infused Intravenously at Different Dosing Regimens, With and Without Methotrexate, Versus Placebo in Adults Gout Patients (RELEASE)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Gout" ], "interventions": [ { "name": "Methotrexate (MTX)", "type": "DRUG" }, { "name": "PRX-115", "type": "BIOLOGICAL" }, { "name": "PRX-115 placebo", "type": "OTHER" }, { "name": "Placebo-Methotrexate", "type": "OTHER" } ], "intervention_types": [ "DRUG", "BIOLOGICAL", "OTHER" ], "sponsor": "Protalix", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 150, "start_date": "2025-12-22", "completion_date": "2028-06", "has_results": false, "last_update_posted_date": "2026-09-29", "last_synced_at": "2026-10-09T00:08:56.436Z", "location_count": 26, "location_summary": "Glendale, Arizona • Little Rock, Arkansas • Anaheim, California + 20 more", "locations": [ { "city": "Glendale", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Anaheim", "state": "California" }, { "city": "El Cajon", "state": "California" }, { "city": "La Palma", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07280156" }, { "nct_id": "NCT07223333", "title": "A Study of PATAS Using Single Ascending Doses in Healthy Volunteers and Multiple Ascending Doses in Diabetic Subjects", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Type 2 Diabetes" ], "interventions": [ { "name": "PATAS Trifluoroacetate", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AdipoPharma LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 56, "start_date": "2026-01-27", "completion_date": "2027-05-30", "has_results": false, "last_update_posted_date": "2026-09-29", "last_synced_at": "2026-10-14T06:15:26.102Z", "location_count": 3, "location_summary": "Chandler, Arizona • Miami, Florida • Port Orange, Florida", "locations": [ { "city": "Chandler", "state": "Arizona" }, { "city": "Miami", "state": "Florida" }, { "city": "Port Orange", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07223333" }, { "nct_id": "NCT07216690", "title": "Pregnenolone as a Treatment for Cannabis Intoxication", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Cannabis Intoxication" ], "interventions": [ { "name": "Cannabis", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Placebo brownie", "type": "DRUG" }, { "name": "Pregnenolone 250 mg", "type": "DRUG" }, { "name": "Pregnenolone 500 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Johns Hopkins University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 20, "start_date": "2026-04-24", "completion_date": "2029-01-01", "has_results": false, "last_update_posted_date": "2026-09-29", "last_synced_at": "2026-10-14T00:20:23.295Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT07216690" }, { "nct_id": "NCT07209462", "title": "Study of MRM-3379 in Male Participants With Fragile X Syndrome (BLOOM)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Fragile X Syndrome" ], "interventions": [ { "name": "High dose of MRM-3379", "type": "DRUG" }, { "name": "Low dose of MRM-3379", "type": "DRUG" }, { "name": "Low dose of MRM-3379 Open-Label", "type": "DRUG" }, { "name": "Middle Dose of MRM-3379", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mirum Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "13 Years", "maximum_age": "45 Years", "sex": "MALE", "summary": "13 Years to 45 Years · Male only" }, "enrollment_count": 60, "start_date": "2025-11-22", "completion_date": "2027-10", "has_results": false, "last_update_posted_date": "2026-09-29", "last_synced_at": "2026-10-14T03:53:36.557Z", "location_count": 15, "location_summary": "Phoenix, Arizona • Irvine, California • Orange, California + 12 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Irvine", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT07209462" }, { "nct_id": "NCT07197944", "title": "Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBS", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Short Bowel Syndrome" ], "interventions": [ { "name": "Glepaglutide", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Zealand Pharma", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "18 Years to 90 Years" }, "enrollment_count": 90, "start_date": "2026-02-11", "completion_date": "2032-02-28", "has_results": false, "last_update_posted_date": "2026-09-29", "last_synced_at": "2026-10-15T13:46:12.451Z", "location_count": 6, "location_summary": "Chicago, Illinois • St Louis, Missouri • Omaha, Nebraska + 3 more", "locations": [ { "city": "Chicago", "state": "Illinois" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Omaha", "state": "Nebraska" }, { "city": "New York", "state": "New York" }, { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT07197944" }, { "nct_id": "NCT07021794", "title": "SARS-CoV-2 Specific Monoclonal Antibody for Post-COVID-19 Conditions (Long COVID)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Post-COVID / Long-COVID" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Sipavibart", "type": "BIOLOGICAL" } ], "intervention_types": [ "DRUG", "BIOLOGICAL" ], "sponsor": "Nancy Klimas", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 100, "start_date": "2025-07-28", "completion_date": "2027-09-30", "has_results": false, "last_update_posted_date": "2026-09-29", "last_synced_at": "2026-10-06T00:15:20.148Z", "location_count": 1, "location_summary": "Fort Lauderdale, Florida", "locations": [ { "city": "Fort Lauderdale", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07021794" }, { "nct_id": "NCT06808477", "title": "A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Atopic Dermatitis" ], "interventions": [ { "name": "BBT001", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bambusa Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "72 Years", "sex": "ALL", "summary": "18 Years to 72 Years" }, "enrollment_count": 237, "start_date": "2025-02-27", "completion_date": "2027-02-28", "has_results": false, "last_update_posted_date": "2026-09-29", "last_synced_at": "2026-10-16T17:30:15.810Z", "location_count": 3, "location_summary": "Irvine, California • New York, New York • The Bronx, New York", "locations": [ { "city": "Irvine", "state": "California" }, { "city": "New York", "state": "New York" }, { "city": "The Bronx", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT06808477" } ] }